Floatz logo

Gly-Low

Hormone Deficiency

Hoskinson Health and Wellness ClinicEarly Phase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Hormone Deficiency cohort.

Asset / SponsorPhaseRating
Genotropin
Max-Planck-Institute of Psychiatry
Phase 2CCC
Testosterone Undecannoate
Max-Planck-Institute of Psychiatry
Phase 2CCC
AE-PEANUT
Al-Balqa Applied University
N/AD
LEUPROLIDE
Pennington Biomedical Research Center
D

Same molecule, other indications

Gly-Low is also rated in:

obesity disorderDormant
CC
Indicative ·
45 / 100
View asset →
Physical DisabilityDormant
CC
Indicative ·
43 / 100
View asset →
hyperlipidemiaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →